- Presentations
- 4
- Markets
- 1
Rystiggo is a brand of Rozanolixizumab marketed by UCB, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Rozanolixizumab
- Brand owner
- UCB
- Registered in
- United States
- Strengths and forms
- 280 mg/2 mL injection, 420 mg/3 mL injection, 560 mg/4 mL injection, 840 mg/6 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Rystiggo 280 mg/2 mL injectionSubcutaneous Cold chain | UCB | US FDA | Available on request |
| Rystiggo 420 mg/3 mL injectionSubcutaneous Cold chain | UCB | US FDA | Available on request |
| Rystiggo 560 mg/4 mL injectionSubcutaneous Cold chain | UCB | US FDA | Available on request |
| Rystiggo 840 mg/6 mL injectionSubcutaneous Cold chain | UCB | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Rystiggo
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.